Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Kwality Pharmaceuticals Ltd

KPL

NSE

₹3,366.00-1.08%19 Oct 2026

Reports

Pharma Formulations

Kwality Pharmaceuticals Ltd

KPL

NSE

₹3,366.00

-1.08%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Pharma Formulations

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹3,516Cr

Close Price

₹3,389.00

Industry

Pharma Formulations

Price To Earnings

43.39

Price To Sales

6.35

Revenue

₹554Cr

Rev Gr TTM

Revenue Growth TTM

37.94%

PAT Gr TTM

PAT Growth TTM

86.84%

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	70	78	92	80	90	84	116	111	111	123	157	162
Growth YoY Revenue Growth YoY%	24.8	39.0	33.7	18.7	29.3	8.1	25.8	39.2	23.4	46.2	35.8	45.6
Expenses ExpensesCr	54	61	71	63	70	67	90	87	86	93	118	121
Operating Profit Operating ProfitCr	15	17	21	17	20	18	26	24	25	30	39	41
OPM OPM%	21.9	21.4	22.4	21.7	21.8	20.7	22.4	21.7	22.8	24.3	24.7	25.3
Other Income Other IncomeCr	0	1	-7	0	0	1	1	0	1	0	1	1
Interest Expense Interest ExpenseCr	2	3	3	2	3	2	2	3	3	2	3	3
Depreciation DepreciationCr	5	5	5	4	5	5	5	5	5	5	5	5
PBT PBTCr	8	10	6	11	13	11	19	17	18	22	32	34
Tax TaxCr	2	2	2	3	4	3	5	5	4	6	6	8
PAT PATCr	6	8	4	8	8	9	14	12	14	16	25	26
Growth YoY PAT Growth YoY%	-33.8	7.6	157.3	54.6	36.0	10.9	241.5	42.8	66.9	87.8	74.8	114.9
NPM NPM%	8.9	9.8	4.6	10.4	9.4	10.1	12.5	10.7	12.7	13.0	16.1	15.8
EPS EPS₹	6.0	7.4	4.1	8.0	8.2	8.2	13.9	11.5	13.6	15.4	24.4	24.7

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	70	78	92	80	90	84	116	111	111	123	157	162
Growth YoY Revenue Growth YoY%	24.8	39.0	33.7	18.7	29.3	8.1	25.8	39.2	23.4	46.2	35.8	45.6
Expenses ExpensesCr	54	61	71	63	70	67	90	87	86	93	118	121
Operating Profit Operating ProfitCr	15	17	21	17	20	18	26	24	25	30	39	41
OPM OPM%	21.9	21.4	22.4	21.7	21.8	20.7	22.4	21.7	22.8	24.3	24.7	25.3
Other Income Other IncomeCr	0	1	-7	0	0	1	1	0	1	0	1	1
Interest Expense Interest ExpenseCr	2	3	3	2	3	2	2	3	3	2	3	3
Depreciation DepreciationCr	5	5	5	4	5	5	5	5	5	5	5	5
PBT PBTCr	8	10	6	11	13	11	19	17	18	22	32	34
Tax TaxCr	2	2	2	3	4	3	5	5	4	6	6	8
PAT PATCr	6	8	4	8	8	9	14	12	14	16	25	26
Growth YoY PAT Growth YoY%	-33.8	7.6	157.3	54.6	36.0	10.9	241.5	42.8	66.9	87.8	74.8	114.9
NPM NPM%	8.9	9.8	4.6	10.4	9.4	10.1	12.5	10.7	12.7	13.0	16.1	15.8
EPS EPS₹	6.0	7.4	4.1	8.0	8.2	8.2	13.9	11.5	13.6	15.4	24.4	24.7

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	74	98	137	166	139	262	456	251	307	370	503	554
Growth Revenue Growth%	41.6	32.5	39.9	20.9	-16.2	88.1	74.1	-45.0	22.4	20.5	35.9	37.9
Expenses ExpensesCr	69	89	126	151	125	233	285	191	241	290	385	419
Operating Profit Operating ProfitCr	5	9	12	16	14	29	172	60	66	80	118	135
OPM OPM%	6.7	9.0	8.5	9.4	10.2	11.0	37.6	24.0	21.6	21.7	23.5	24.4
Other Income Other IncomeCr	0	1	1	1	4	2	4	-14	-5	2	2	2
Interest Expense Interest ExpenseCr	1	2	2	2	3	3	3	6	10	10	11	11
Depreciation DepreciationCr	2	3	3	3	4	6	11	15	20	18	20	20
PBT PBTCr	2	6	7	11	11	21	162	26	31	54	89	106
Tax TaxCr	1	2	3	3	3	6	42	6	7	14	22	25
PAT PATCr	1	3	4	8	8	15	120	19	24	40	67	81
Growth PAT Growth%	59.9	155.8	34.9	70.9	8.6	81.4	705.6	-83.9	22.5	68.5	69.2	86.8
NPM NPM%	1.7	3.3	3.2	4.5	5.9	5.7	26.3	7.7	7.7	10.8	13.4	14.6
EPS EPS₹	0.0	3.2	4.4	7.3	8.0	14.6	115.6	18.2	22.8	38.4	64.9	78.1

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	74	98	137	166	139	262	456	251	307	370	503	554
Growth Revenue Growth%	41.6	32.5	39.9	20.9	-16.2	88.1	74.1	-45.0	22.4	20.5	35.9	37.9
Expenses ExpensesCr	69	89	126	151	125	233	285	191	241	290	385	419
Operating Profit Operating ProfitCr	5	9	12	16	14	29	172	60	66	80	118	135
OPM OPM%	6.7	9.0	8.5	9.4	10.2	11.0	37.6	24.0	21.6	21.7	23.5	24.4
Other Income Other IncomeCr	0	1	1	1	4	2	4	-14	-5	2	2	2
Interest Expense Interest ExpenseCr	1	2	2	2	3	3	3	6	10	10	11	11
Depreciation DepreciationCr	2	3	3	3	4	6	11	15	20	18	20	20
PBT PBTCr	2	6	7	11	11	21	162	26	31	54	89	106
Tax TaxCr	1	2	3	3	3	6	42	6	7	14	22	25
PAT PATCr	1	3	4	8	8	15	120	19	24	40	67	81
Growth PAT Growth%	59.9	155.8	34.9	70.9	8.6	81.4	705.6	-83.9	22.5	68.5	69.2	86.8
NPM NPM%	1.7	3.3	3.2	4.5	5.9	5.7	26.3	7.7	7.7	10.8	13.4	14.6
EPS EPS₹	0.0	3.2	4.4	7.3	8.0	14.6	115.6	18.2	22.8	38.4	64.9	78.1

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	5	5	10	10	10	10	10	10	10	10	10
Reserves ReservesCr	17	20	19	27	36	51	171	190	214	254	321
Current Liabilities Current LiabilitiesCr	27	42	62	61	68	78	139	126	152	170	226
Non Current Liabilities Non Current LiabilitiesCr	3	4	5	8	20	28	21	29	20	15	37
Total Liabilities Total LiabilitiesCr	51	71	96	105	133	166	341	354	394	447	592
Current Assets Current AssetsCr	38	53	75	75	89	106	228	207	243	284	406
Non Current Assets Non Current AssetsCr	13	18	21	30	44	60	113	146	152	163	187
Total Assets Total AssetsCr	51	71	96	105	133	166	341	354	394	447	592

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	5	5	10	10	10	10	10	10	10	10	10
Reserves ReservesCr	17	20	19	27	36	51	171	190	214	254	321
Current Liabilities Current LiabilitiesCr	27	42	62	61	68	78	139	126	152	170	226
Non Current Liabilities Non Current LiabilitiesCr	3	4	5	8	20	28	21	29	20	15	37
Total Liabilities Total LiabilitiesCr	51	71	96	105	133	166	341	354	394	447	592
Current Assets Current AssetsCr	38	53	75	75	89	106	228	207	243	284	406
Non Current Assets Non Current AssetsCr	13	18	21	30	44	60	113	146	152	163	187
Total Assets Total AssetsCr	51	71	96	105	133	166	341	354	394	447	592

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-3	4	-1	14	6	27	61	41	43	53	17
Investing Cash Flow Investing Cash FlowCr	-2	-7	-6	-12	-18	-23	-63	-48	-26	-29	-35
Financing Cash Flow Financing Cash FlowCr	6	5	5	-2	12	1	6	1	-17	-14	7
Net Cash Flow Net Cash FlowCr	0	2	-1	0	0	4	3	-6	-1	10	-11
Free Cash Flow Free Cash FlowCr	-5	-3	-7	2	-12	3	5	-4	17	30	-24
CFO To PAT CFO To PAT%	-222.0	131.1	-12.9	179.7	75.1	179.4	50.5	214.6	182.0	132.4	25.3
CFO To EBITDA CFO To EBITDA%	-57.0	48.7	-4.9	86.4	43.4	92.6	35.3	68.8	64.8	65.6	14.4

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-3	4	-1	14	6	27	61	41	43	53	17
Investing Cash Flow Investing Cash FlowCr	-2	-7	-6	-12	-18	-23	-63	-48	-26	-29	-35
Financing Cash Flow Financing Cash FlowCr	6	5	5	-2	12	1	6	1	-17	-14	7
Net Cash Flow Net Cash FlowCr	0	2	-1	0	0	4	3	-6	-1	10	-11
Free Cash Flow Free Cash FlowCr	-5	-3	-7	2	-12	3	5	-4	17	30	-24
CFO To PAT CFO To PAT%	-222.0	131.1	-12.9	179.7	75.1	179.4	50.5	214.6	182.0	132.4	25.3
CFO To EBITDA CFO To EBITDA%	-57.0	48.7	-4.9	86.4	43.4	92.6	35.3	68.8	64.8	65.6	14.4

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr		50	43	38	27	58	602	319	425	902	1,355	3,516
Price To Earnings Price To Earnings		14.8	9.4	5.1	3.2	3.8	5.0	16.5	17.9	22.6	20.1	43.4
Price To Sales Price To Sales		0.5	0.3	0.2	0.2	0.2	1.3	1.3	1.4	2.4	2.7	6.3
Price To Book Price To Book		2.0	1.5	1.1	0.6	1.0	3.3	1.6	1.9	3.4	4.1	10.6
EV To EBITDA EV To EBITDA		7.4	5.7	4.0	4.0	3.0	3.8	6.7	7.8	12.4	12.5	27.1
Profitability Ratios Profitability Ratios
GPM GPM%	18.3	23.9	20.8	24.3	32.4	33.0	52.6	48.9	42.3	43.5	42.7	42.7
OPM OPM%	6.7	9.0	8.5	9.4	10.2	11.0	37.6	24.0	21.6	21.7	23.5	24.4
NPM NPM%	1.7	3.3	3.2	4.5	5.9	5.7	26.3	7.7	7.7	10.8	13.4	14.6
ROCE ROCE%	10.8	17.1	17.0	20.7	17.3	25.0	70.0	10.9	12.9	17.0	21.7	21.7
ROE ROE%	5.9	12.8	14.9	20.3	17.8	24.3	66.2	9.6	10.5	15.1	20.3	20.3
ROA ROA%	2.5	4.6	4.6	7.2	6.2	8.9	35.2	5.5	6.0	8.9	11.4	11.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr		50	43	38	27	58	602	319	425	902	1,355	3,516
Price To Earnings Price To Earnings		14.8	9.4	5.1	3.2	3.8	5.0	16.5	17.9	22.6	20.1	43.4
Price To Sales Price To Sales		0.5	0.3	0.2	0.2	0.2	1.3	1.3	1.4	2.4	2.7	6.3
Price To Book Price To Book		2.0	1.5	1.1	0.6	1.0	3.3	1.6	1.9	3.4	4.1	10.6
EV To EBITDA EV To EBITDA		7.4	5.7	4.0	4.0	3.0	3.8	6.7	7.8	12.4	12.5	27.1
Profitability Ratios Profitability Ratios
GPM GPM%	18.3	23.9	20.8	24.3	32.4	33.0	52.6	48.9	42.3	43.5	42.7	42.7
OPM OPM%	6.7	9.0	8.5	9.4	10.2	11.0	37.6	24.0	21.6	21.7	23.5	24.4
NPM NPM%	1.7	3.3	3.2	4.5	5.9	5.7	26.3	7.7	7.7	10.8	13.4	14.6
ROCE ROCE%	10.8	17.1	17.0	20.7	17.3	25.0	70.0	10.9	12.9	17.0	21.7	21.7
ROE ROE%	5.9	12.8	14.9	20.3	17.8	24.3	66.2	9.6	10.5	15.1	20.3	20.3
ROA ROA%	2.5	4.6	4.6	7.2	6.2	8.9	35.2	5.5	6.0	8.9	11.4	11.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	FDC	RPGLIFE	GUFICBIO	KPL	INDSWFTLAB	FREDUN	INDOCO
Market CapitalizationMkt CapCr	5,570	4,712	4,051	3,516	3,044	2,373	2,177
Close PriceClose₹	342.10	2,849.00	404.00	3,389.00	350.00	1,435.00	235.90
IndustryIndustry	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations
Price To EarningsPE	19.03	39.38	55.19	43.39	51.32	50.23	737.19
Price To SalesPS	2.54	6.42	4.13	6.35	4.58	3.17	1.16
RevenueRevenueCr	2,190	734	981	554	665	748	1,873
Revenue Growth TTMRev Gr TTM%	3.4%		16.7%	37.9%	54.0%		12.0%
PAT Growth TTMPAT Gr TTM%	8.7%		18.7%	86.8%	-74.7%		102.7%

	FDC	RPGLIFE	GUFICBIO	KPL	INDSWFTLAB	FREDUN	INDOCO
Market CapitalizationMkt CapCr	5,570	4,712	4,051	3,516	3,044	2,373	2,177
Close PriceClose₹	342.10	2,849.00	404.00	3,389.00	350.00	1,435.00	235.90
IndustryIndustry	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations	Pharma Formulations
Price To EarningsPE	19.03	39.38	55.19	43.39	51.32	50.23	737.19
Price To SalesPS	2.54	6.42	4.13	6.35	4.58	3.17	1.16
RevenueRevenueCr	2,190	734	981	554	665	748	1,873
Revenue Growth TTMRev Gr TTM%	3.4%		16.7%	37.9%	54.0%		12.0%
PAT Growth TTMPAT Gr TTM%	8.7%		18.7%	86.8%	-74.7%		102.7%